XML 38 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Balance sheet information (Tables)
 3 Months Ended
Apr. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Accounts Receivable
Accounts receivable, net of allowances, consisted of the following as of:
April 1, 2023December 31, 2022
Accounts receivable(a)
$125,945 $143,317 
Less: Allowance for credit losses(b)
(7,401)(7,022)
$118,544 $136,295 
(a)Other receivables of $350 attributable to CartiHeal was reclassified to current assets attributable to discontinued operations within the December 31, 2022 consolidated balance sheets. Accounts receivable of $5,012 was reclassified into assets held for sale within the April 1, 2023 consolidated condensed balance sheets. Refer to Note 3. Acquisitions and divestitures and Note 14. Discontinued operations for further details regarding assets held for sale and the deconsolidation of CartiHeal.
(b)Allowance for credit losses of $898 was reclassified to assets held for sale within the April 1, 2023 consolidated condensed balance sheets. Refer to Note 3. Acquisitions and divestitures for further details regarding assets held for sale.
Schedule of Accounts Receivable, Allowance for Credit Loss
Changes in credit losses were as follows:
Three Months Ended
April 1, 2023April 2, 2022
Beginning balance$(7,022)$(3,402)
Provision for losses(1,079)(1,152)
Write-offs286 369 
Recoveries(484)(69)
Reclassification to held for sale898 — 
Ending balance$(7,401)$(4,254)
Schedule of Inventory
Inventory consisted of the following as of:
April 1, 2023December 31, 2022
Raw materials and supplies(a)
$24,729 $19,133 
Finished goods(b)
65,461 67,484 
Gross90,190 86,617 
Excess and obsolete reserves(2,237)(1,851)
$87,953 $84,766 
(a)Raw material inventory of $642 attributable to CartiHeal has been reclassified to current assets attributable to discontinued operations within the December 31, 2022 consolidated balance sheets. Refer to Note 3. Acquisitions and divestitures and Note 14. Discontinued operations for further details regarding the deconsolidation of CartiHeal.
(b)Finished goods inventory of $1,481 was reclassified to assets held for sale within the April 1, 2023 consolidated condensed balance sheets. Refer to Note 3. Acquisitions and divestitures for further information.
Schedule of Prepaid and Other Current Assets
Prepaid and other current assets consisted of the following as of:
April 1, 2023December 31, 2022
Prepaid taxes$4,400 $4,442 
Prepaid and other current assets(a)
12,792 14,109 
$17,192 $18,551 
(a)Prepaid and other current assets of $134 attributable to CartiHeal was reclassified to current assets attributable to discontinued operations within the December 31, 2022 balance sheet. Refer to Note 3. Acquisitions and divestitures and Note 14. Discontinued operations for further details regarding the deconsolidation of CartiHeal.
Schedule of Finite-Lived Intangible Assets
Intangible assets consisted of the following as of:
April 1, 2023December 31, 2022
Intellectual property(a)(b)(c)
$676,549 $790,049 
Distribution rights61,325 61,325 
Customer relationships(b)
57,950 67,450 
IPR&D5,500 5,500 
Developed technology and other13,998 13,998 
Total carrying amount815,322 938,322 
Less accumulated amortization:
Intellectual property(a)(b)(c)
(188,094)(187,767)
Distribution rights(45,563)(44,319)
Customer relationships(b)
(57,950)(58,842)
Developed technology and other(6,587)(6,276)
Total accumulated amortization(298,194)(297,204)
Intangible assets, net before currency translation517,128 641,118 
Currency translation(1,089)(1,267)
$516,039 $639,851 
(a)Intellectual property and accumulated depreciation attributable to CartiHeal totaling $410,200 and $11,327, respectively, were reclassified to long-term assets attributable to discontinued operations within the December 31, 2022 consolidated balance sheets. Refer to Note 3. Acquisitions and divestitures and Note 14. Discontinued operations for further details regarding the deconsolidation of CartiHeal.
(b)Net intellectual property and customer relationships of $23,458 and $8,377, respectively, were reclassified into assets held for sale within the April 1, 2023 consolidated condensed balance sheets. Refer to Note 3. Acquisitions and divestitures for further details regarding assets held for sale.
(c)The Company recorded an impairment loss of $78,615 in the U.S. reporting segment of net intellectual property attributable to a business held for sale. The loss was recorded in impairment of assets within the consolidated condensed statements of operations and comprehensive loss. Refer to Refer to Note 3. Acquisitions and divestitures for further details regarding businesses held for sale.
Schedule of Accrued Liabilities
Accrued liabilities consisted of the following as of:
April 1, 2023December 31, 2022
Gross-to-net deductions$66,557 $71,227 
Bonus and commission(a)
9,462 9,179 
Compensation and benefits6,843 11,428 
Accrued interest6,210 217 
Income and other taxes4,496 2,572 
Other liabilities(b)
22,201 16,947 
$115,769 $111,570 
(a)Bonus and commissions of $588 were reclassified into liabilities held for sale within the April 1, 2023 consolidated balance sheets. Refer to Note 3. Acquisitions and divestitures for further details.
(b)Other liabilities attributable to CartiHeal of $384 were reclassified into current liabilities attributable to discontinued operations within December 31, 2022 consolidated balance sheets. Refer to Note 3. Acquisitions and divestitures and Note 14. Discontinued operations for further details.